Key references: Toxoplasma gondii prophylaxis in immunocompromised adults without HIV infection

  • Hughes WT. Use of dapsone in the prevention and treatment of Pneumocystis carinii pneumonia: a review. Clin Infect Dis 1998;27(1):191–204. https://www.ncbi.nlm.nih.gov/pubmed/9675476
  • Mendorf A, Klyuchnikov E, Langebrake C, Rohde H, Ayuk F, Regier M, et al. Atovaquone for prophylaxis of toxoplasmosis after allogeneic hematopoietic stem cell transplantation. Acta Haematol 2015;134(3):146–54. https://www.ncbi.nlm.nih.gov/pubmed/25968483
  • Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. Rockville, MD: US Department of Health and Human Services (DHHS); 2013 [updated 2017]. http://aidsinfo.nih.gov/guidelines/html/4/adult-and-adolescent-oi-prevention-and-treatment-guidelines/0
  • Schwartz BS, Mawhorter SD. Parasitic infections in solid organ transplantation. Am J Transplant 2013;13(4):280–303 .https://www.ncbi.nlm.nih.gov/pubmed/23465021
  • Slavin MA, Meyers JD, Remington JS, Hackman RC. Toxoplasma gondii infection in marrow transplant recipients: a 20 year experience. Bone Marrow Transplant 1994;13(5):549–57. https://www.ncbi.nlm.nih.gov/pubmed/8054907
  • Tomblyn M, Chiller T, Einsele H, Gress R, Sepkowitz K, Storek J, et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant 2009;15(10):1143–238. https://www.ncbi.nlm.nih.gov/pubmed/19747629